Black Titan Corp

Black Titan Corp(BTTC)股票分析

$0.280

-0.001 (-0.36%)收盘时

Loading chart…
最高
0.309
开盘
0.285
成交量加权均价
0.29
成交量
92.11K
市值
—
最低
0.280
成交额
26.67K
企业价值/息税折旧摊销前利润(TTM)
0.00

Black Titan Corporation is a holding company that operates through its subsidiaries, Titan Pharmaceuticals Inc. (TTNP), and TalenTec Sdn Bhd (TalenTec). TTNP is a pharmaceutical company that was previously developing therapeutics utilizing the proprietary long-term drug delivery platform, ProNeura, for the treatment of select chronic diseases. ProNeura consists of a small, solid implant made from a mixture of ethylene-vinyl acetate (EVA) and a drug substance. The resulting product is a solid matrix that is designed to be administered sub-dermally in a brief, outpatient procedure and is removed in a similar manner at the end of the treatment period. TalenTec is a provider of HCM software in Malaysia. It has introduced numerous human capital management (HCM) solutions to that market, such as Oracle PeopleSoft HCM, Oracle PeopleSoft Financials, Sunfish Workplaze HR, DayForce HCM, and MiHCM Cloud, through its holistic, integrated and reliable services.

AI 分析 of Black Titan Corp (BTTC)

卖出

Black Titan Corp is not a good buy right now due to its extremely low RSI of 22.133, indicating oversold conditions, and a staggering year-to-date change of -84.69%.

估值指标

Black Titan Corp(BTTC)当前预期市盈率为 0.00,5 年平均预期市盈率为 0.00。

预期市盈率

严重低估
5 年均值 P/E
0.00
当前P/E
0.00
高估
0.00
低估
0.00

预期 EV/EBITDA

严重低估
5 年均值 EV/EBITDA
0.00
当前EV/EBITDA
0.00
高估
0.00
低估
0.00

预期市销率

严重低估
5 年均值 P/S
0.00
当前P/S
0.00
高估
0.00
低估
0.00

事件时间线

2026-07-21 (ET)

09:30:00

Black Titan Announces Strategic Growth Initiatives to Expand Southeast Asia Market

2026-02-19 (ET)

10:40:00

Black Titan Corporation Signs Strategic MOU with PyratzLabs

2025-12-11 (ET)

09:40:00

Black Titan Releases Second Pillar of DAT+ Strategic Framework

08:50:00

Black Titan Introduces Digital Asset Strategic Framework DAT+

2025-11-12 (ET)

08:39:44

Black Titan names Lin as co-CEO

资讯

BTTC 常见问题 —— 由 Alphio AI 解答

Black Titan Corporation is a holding company that operates through its subsidiaries, Titan Pharmaceuticals Inc. (TTNP), and TalenTec Sdn Bhd (TalenTec). TTNP is a pharmaceutical company that was previously developing therapeutics utilizing the proprietary long-term drug delivery platform, ProNeura, for the treatment of select chronic diseases. ProNeura consists of a small, solid implant made from a mixture of ethylene-vinyl acetate (EVA) and a drug substance. The resulting product is a solid matrix that is designed to be administered sub-dermally in a brief, outpatient procedure and is removed in a similar manner at the end of the treatment period. TalenTec is a provider of HCM software in Malaysia. It has introduced numerous human capital management (HCM) solutions to that market, such as Oracle PeopleSoft HCM, Oracle PeopleSoft Financials, Sunfish Workplaze HR, DayForce HCM, and MiHCM Cloud, through its holistic, integrated and reliable services. It operates in the Financials sector.

Black Titan Corp is not a good buy right now due to its extremely low RSI of 22.133, indicating oversold conditions, and a staggering year-to-date change of -84.69%.

onyx_warden2026/9/27

# China and the U.S. Reach Consensus on $30 Billion in Tariff Reductions 🔥 Breaking: China and the U.S. have reached a consensus on $30 billion in tariff reductions. What does this mean for crypto? Core logic: Easing trade tensions reduce global geopolitical risk, which lifts risk appetite and is theoretically bullish for risk assets like BTC. ⚠️ But the key point: this tariff cut was already expected, so the positive news has likely been priced in ahead of time, making a sustained rally unlikely. What truly determines the broader direction of crypto is still Fed interest rates and U.S. crypto regulation policy. Tariffs are only a secondary catalyst. Question: In the short term, are you bullish on a rebound, or do you think the news is already priced in and could turn into a sell-the-news event? #CryptoNews #MacroMarket #btc70k

展开
注册或登录后参与讨论

相关文章

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易